Compare, Analyse Lupin Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs TEVA PHARMA (Israel) - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-19
TEVA PHARMA
Dec-13
LUPIN/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs9863,138-   
Low Rs7202,726-   
Sales per share (Unadj.) Rs369.51,800.7-  
Earnings per share (Unadj.) Rs13.4112.5-  
Cash flow per share (Unadj.) Rs37.4258.0-  
Dividends per share (Unadj.) Rs098.47-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs303.72,000.2-  
Shares outstanding (eoy) m452.49848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.31.6 141.8%   
Avg P/E ratio x63.626.1 244.2%  
P/CF ratio (eoy) x22.811.4 200.9%  
Price / Book Value ratio x2.81.5 191.7%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m386,0642,486,022 15.5%   
No. of employees `00017.744.9 39.3%   
Total wages/salary Rs m31,5130-   
Avg. sales/employee Rs Th9,453.833,974.9 27.8%   
Avg. wages/employee Rs Th1,782.00-   
Avg. net profit/employee Rs Th343.02,122.4 16.2%   
INCOME DATA
Net Sales Rs m167,1821,527,003 10.9%  
Other income Rs m3,6400-   
Total revenues Rs m170,8221,527,003 11.2%   
Gross profit Rs m28,822418,171 6.9%  
Depreciation Rs m10,850123,429 8.8%   
Interest Rs m3,07829,993 10.3%   
Profit before tax Rs m18,534264,749 7.0%   
Minority Interest Rs m-891,203 -7.4%   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,400-173,793 2.0%   
Tax Rs m9,017-3,232 -279.0%   
Profit after tax Rs m6,06695,391 6.4%  
Gross profit margin %17.227.4 63.0%  
Effective tax rate %48.7-1.2 -3,984.8%   
Net profit margin %3.66.2 58.1%  
BALANCE SHEET DATA
Current assets Rs m138,5361,031,332 13.4%   
Current liabilities Rs m61,299899,409 6.8%   
Net working cap to sales %46.28.6 534.8%  
Current ratio x2.31.1 197.1%  
Inventory Days Days8491 92.3%  
Debtors Days Days11296 117.2%  
Net fixed assets Rs m127,516498,753 25.6%   
Share capital Rs m9053,759 24.1%   
"Free" reserves Rs m136,5170-   
Net worth Rs m137,4221,696,211 8.1%   
Long term debt Rs m66,417780,791 8.5%   
Total assets Rs m279,4943,489,692 8.0%  
Interest coverage x7.09.8 71.4%   
Debt to equity ratio x0.50.5 105.0%  
Sales to assets ratio x0.60.4 136.7%   
Return on assets %3.33.6 91.1%  
Return on equity %4.45.6 78.5%  
Return on capital %8.94.9 180.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m37,1320-   
CASH FLOW
From Operations Rs m16,660243,325 6.8%  
From Investments Rs m-32,825-86,220 38.1%  
From Financial Activity Rs m7,441-291,885 -2.5%  
Net Cashflow Rs m-8,724-134,780 6.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.17 Rs / USD

Compare LUPIN With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare LUPIN With: DISHMAN PHARMA  ALEMBIC LTD  UNICHEM LAB  CADILA HEALTHCARE  GLENMARK PHARMA  



Today's Market

Sensex Ends Marginally Higher; Energy and IT Stocks Witness Buying(Closing)

After opening the day on a strong note, Indian share markets erased most of the gains and turned highly volatile in the afternoon session.

Related Views On News

LUPIN Announces Quarterly Results (4QFY20); Net Profit Up 35.5% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (2QFY20); Net Profit Down 146.4% (Quarterly Result Update)

Nov 7, 2019 | Updated on Nov 7, 2019

For the quarter ended September 2019, LUPIN has posted a net profit of Rs 1 bn (down 146.4% YoY). Sales on the other hand came in at Rs 44 bn (up 10.3% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium (Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying? (Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

LUPIN SHARE PRICE


Jul 13, 2020 (Close)

TRACK LUPIN

MORE ON LUPIN

LUPIN 8-QTR ANALYSIS

COMPARE LUPIN WITH

FEATURED VIDEOS

MARKET STATS